// App-Quantinova.ai

TCT-729 : Four-Year Clinical Outcomes in ‘Real-World’ Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent: Results from the PROMUS Element Plus US Post-Approval Study (PE-Plus PAS)

Researchers

Presenter

  • David Kandzari

Principal Investigators

  • Peter Ver Lee

  • Anil Chhabra

  • Jerrold Grodin

  • Maria Bartlett

  • Richard Zelman

  • Walt Marquardt

  • Thomas Christen

  • Ian Meredith

Medical Centers

  • Coliseum Medical Center, Macon, Georgia, United States

  • Eastern Maine Medical Center, Bangor, Maine, United States

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • Mercy General Hospital, Sacramento, California, United States

  • Cape Cod Hospital, Hyannis, Massachusetts, United States

  • Dallas VA Hospital, Dallas, Texas, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Promus Element

  • Everolimus

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved